Digital Therapeutics and FDA Regulations

The use of digital therapeutics (DTx) is on the rise. Fueled by shifting models of care as a result of the coronavirus pandemic, the DTx market is expected to reach $10.62 billion by 2025. While DTx offer unique opportunities within the life science product industry,...

Ask the Expert: How to Survive an FDA Inspection

This is the third of our “Ask the Expert” blogs, a series featuring the wisdom and seasoned insight of Pearl Pathways Advisors and Consultant Advisors. Pearl Pathways Director of QA/RA Services, Beckinam Nowatzke, was interviewed for this piece. If you have any...